ClearPoint Neuro, Inc. (CLPT) vs Viemed Healthcare, Inc. (VMD)

ClearPoint Neuro, Inc. and Viemed Healthcare, Inc. are both Medical Devices companies. Viemed Healthcare, Inc. is the larger, with a market value of $371.4M against $294.1M — 1.3× the size. ClearPoint Neuro, Inc. has negative trailing earnings, so its P/E is not meaningful; Viemed Healthcare, Inc. trades at 24.9×. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 25.2%. Viemed Healthcare, Inc. has the higher net margin (4.81% vs −81.8%) and the higher return on invested capital (10.7% vs −61.3%). Across the 19 metrics below, Viemed Healthcare, Inc. leads on 13 and ClearPoint Neuro, Inc. on 6.

Valuation

Metric CLPT VMD Medical Devices median
P/E n/m 24.95 23.22
P/S 6.47 1.20 2.34
P/B 25.39 2.48 2.33
Price to free cash flow n/m 10.53 23.72
EV/EBITDA n/m 6.55 11.54
EV/Sales 6.97 1.19 2.24
Earnings yield (13.01%) 4.01% (10.09%)
Free cash flow yield (11.64%) 9.50% (8.47%)

Profitability

Metric CLPT VMD Medical Devices median
Gross margin 62.61% 57.47% 56.01%
Operating margin (73.42%) 8.05% (15.03%)
Net margin (81.76%) 4.81% (20.40%)
Free cash flow margin (74.01%) 11.42% (7.24%)
Return on equity (226.52%) 10.08% (15.32%)
Return on assets (46.21%) 7.46% (19.72%)
Return on invested capital (61.31%) 10.66% (10.33%)

Growth

Metric CLPT VMD Medical Devices median
Revenue growth (TTM) 25.86% 25.21% 8.80%
EPS growth (last fiscal year) (28.57%) 32.14% 29.03%
Revenue growth, 5-year CAGR 23.58% 15.53% 15.47%
Net income growth, 5-year CAGR 0.00% (13.88%) 0.00%

Health

Metric CLPT VMD Medical Devices median
Debt to equity 4.66 0.05 0.07
Current ratio 4.74 1.13 2.50
Net debt to EBITDA (0.14) (0.02) 0.49

Dividend

Metric CLPT VMD Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric CLPT VMD Medical Devices median
Market cap 294.06m 371.36m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack